Acquisition of Data Management and Analysis Platform for Real-Time Process Monitoring and Reporting Announced

Merck has acquired all ownership rights to the ProcessPad™ platform from Simplyfeye Softwares Private Ltd. The agreement includes the transfer of all copyrights and relevant intellectual property related to this software platform.
 
The ProcessPad™ platform is a data management and analytics solution developed specifically for the pharmaceutical and biopharmaceutical industry. 

The platform: aggregates data from a variety of external data sources for various batches, parameters and unit operations, efficiently capturing all development, scale-up, commercial and process data on one single platform; analyses quantitative and qualitative batch manufacturing data using various process analysis tools, which also aid in troubleshooting; visualises the data by generating a variety of report, charts, and tables for annual product reviews, root cause investigations and corrective and preventive action (CAPA) implementation; manages data simply through easy browser-based access to all process data from a variety of diverse stakeholders.
 
The acquisition of the platform is another building block for Merck’s BioContinuum™ Platform, a confluent offering of intensified, advanced processing and digital technologies and services that allow a customer to go beyond continuous processing. The BioContinuum™ Platform will deliver contiguous manufacturing for Biopharma 4.0, the industry-specific global vision and initiative based on Industry 4.0.